PRAX-222
PRAX-222-311
Phase 3 small_molecule active
Quick answer
PRAX-222 for Voltage-gated sodium channel type II alpha subunit (SCN2A) developmental and epileptic encephalopathy (DEE) is a Phase 3 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- Voltage-gated sodium channel type II alpha subunit (SCN2A) developmental and epileptic encephalopathy (DEE)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active